Adlai Nortye Group Ltd., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20__ Debt SecuritiesIndenture • September 11th, 2026 • Adlai Nortye Group Ltd. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 11th, 2026 Company Industry JurisdictionIndenture, dated as of [●], 20__, among Adlai Nortye Group Ltd., a public company limited by shares incorporated under the laws of Singapore (the “Company”), and [Trustee], as trustee (the “Trustee”):
Keros Therapeutics, Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [l], 20__ Debt SecuritiesIndenture • September 10th, 2026 • Keros Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 10th, 2026 Company Industry JurisdictionINDENTURE, dated as of [l], 20__, among Keros Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):